Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.52 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | EPOR | P19235 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16947980 | 0.99 | GLP1R (0.53) | GLP1RNOD1EPHX2ADRA1AEPOR | |
| SCHEMBL20652648 | 0.91 | GLP1R (0.54) | GLP1RNOD1EPHX2EPORITGB3 | |
| SCHEMBL20653022 | 0.91 | GLP1R (0.54) | GLP1RNOD1EPHX2EPORITGB3 | |
| SCHEMBL20652822 | 0.91 | GLP1R (0.54) | GLP1RNOD1EPHX2EPORITGB3 | |
| SCHEMBL20652766 | 0.91 | GLP1R (0.54) | GLP1RNOD1EPHX2EPORITGB3 | |
| SCHEMBL24890886 | 0.90 | GLP1R (0.67) | GLP1RNOD1FOLH1 | |
| SCHEMBL16638273 | 0.90 | GLP1R (0.67) | GLP1RNOD1FOLH1 | |
| SCHEMBL24891117 | 0.90 | GLP1R (0.67) | GLP1RNOD1FOLH1 | |
| SCHEMBL16947959 | 0.90 | GLP1R (0.67) | GLP1RNOD1FOLH1 | |
| SCHEMBL16947828 | 0.90 | GLP1R (0.67) | GLP1RNOD1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021186169-A1 | ORAL GLP RECEPTOR AGONISTS | HEPTARES THERAPEUTICS LIMITED (GB) | 2021-09-23 | — | — | WO | disclosed |